S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
"We need batteries. Literally everywhere." (Ad)
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Costco vs Amazon: an end of the year showdown
"We need batteries. Literally everywhere." (Ad)
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Closing prices for crude oil, gold and other commodities
"We need batteries. Literally everywhere." (Ad)
Discount Retailers Could Make Good Bargain Stocks
How major US stock indexes fared Friday 12/9/2022
S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
"We need batteries. Literally everywhere." (Ad)
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Costco vs Amazon: an end of the year showdown
"We need batteries. Literally everywhere." (Ad)
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Closing prices for crude oil, gold and other commodities
"We need batteries. Literally everywhere." (Ad)
Discount Retailers Could Make Good Bargain Stocks
How major US stock indexes fared Friday 12/9/2022
S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
"We need batteries. Literally everywhere." (Ad)
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Costco vs Amazon: an end of the year showdown
"We need batteries. Literally everywhere." (Ad)
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Closing prices for crude oil, gold and other commodities
"We need batteries. Literally everywhere." (Ad)
Discount Retailers Could Make Good Bargain Stocks
How major US stock indexes fared Friday 12/9/2022
S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
"We need batteries. Literally everywhere." (Ad)
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Costco vs Amazon: an end of the year showdown
"We need batteries. Literally everywhere." (Ad)
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Closing prices for crude oil, gold and other commodities
"We need batteries. Literally everywhere." (Ad)
Discount Retailers Could Make Good Bargain Stocks
How major US stock indexes fared Friday 12/9/2022
NASDAQ:LMAT

LeMaitre Vascular - LMAT Stock Forecast, Price & News

$46.42
-0.09 (-0.19%)
(As of 12/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$46.28
$47.15
50-Day Range
$41.94
$52.25
52-Week Range
$38.32
$56.38
Volume
54,836 shs
Average Volume
105,351 shs
Market Capitalization
$1.02 billion
P/E Ratio
48.35
Dividend Yield
1.08%
Price Target
$50.00

LeMaitre Vascular MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
7.7% Upside
$50.00 Price Target
Short Interest
Healthy
2.82% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
0.43mentions of LeMaitre Vascular in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$349,875 Sold Last Quarter
Proj. Earnings Growth
9.26%
From $1.08 to $1.18 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.38 out of 5 stars

Medical Sector

226th out of 1,034 stocks

Surgical & Medical Instruments Industry

26th out of 101 stocks

LMAT stock logo

About LeMaitre Vascular (NASDAQ:LMAT) Stock

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Receive LMAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LeMaitre Vascular and its competitors with MarketBeat's FREE daily newsletter.

LMAT Stock News Headlines

ESLOY vs. LMAT: Which Stock Is the Better Value Option?
Is This Underfollowed Dividend Stock a Buy?
LeMaitre stock slumps 16% amid Q3 miss, slashed outlook
LeMaitre Q3 2022 Financial Results
LMAT LeMaitre Vascular, Inc.
LeMaitre Vascular (LMAT) Lags Q2 Earnings Estimates
LeMaitre Q2 2022 Financial Results
See More Headlines
Receive LMAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LeMaitre Vascular and its competitors with MarketBeat's FREE daily newsletter.

LMAT Company Calendar

Last Earnings
10/27/2022
Ex-Dividend for 12/1 Dividend
11/16/2022
Dividend Payable
12/01/2022
Today
12/09/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/23/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LMAT
Employees
450
Year Founded
1983

Price Target and Rating

Average Stock Price Forecast
$50.00
High Stock Price Forecast
$50.00
Low Stock Price Forecast
$50.00
Forecasted Upside/Downside
+7.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$26.91 million
Pretax Margin
17.23%

Debt

Sales & Book Value

Annual Sales
$154.42 million
Cash Flow
$1.76 per share
Book Value
$11.64 per share

Miscellaneous

Free Float
19,251,000
Market Cap
$1.02 billion
Optionable
Optionable
Beta
1.03

Social Links


Key Executives

  • Mr. George W. LeMaitreMr. George W. LeMaitre (Age 57)
    Chairman & CEO
    Comp: $882.03k
  • Mr. David B. RobertsMr. David B. Roberts (Age 58)
    Pres & Director
    Comp: $603.01k
  • Mr. Joseph P. Pellegrino Jr. (Age 57)
    CFO, Treasurer, Sec. & Director
    Comp: $518.6k
  • Mr. Trent G. KamkeMr. Trent G. Kamke (Age 51)
    Sr. VP of Operations
    Comp: $368.62k
  • Dr. George D. LeMaitreDr. George D. LeMaitre (Age 88)
    Founder and Chairman of Scientific Advisory Board
  • Ms. Laurie A. Churchill (Age 51)
    Sr. VP & Gen. Counsel
  • Ms. Kimberly L. Cieslak (Age 49)
    VP of Marketing
  • Mr. Daniel J. Mumford (Age 40)
    Director of HR
  • Mr. Andrew Hodgkinson (Age 46)
    Sr. VP of Clinical, Regulatory & Quality Affairs
  • Mr. Stephane Maier (Age 46)
    Sr. VP of EMEA Operations













LMAT Stock - Frequently Asked Questions

Should I buy or sell LeMaitre Vascular stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for LeMaitre Vascular in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" LMAT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LMAT, but not buy additional shares or sell existing shares.
View LMAT analyst ratings
or view top-rated stocks.

What is LeMaitre Vascular's stock price forecast for 2023?

1 brokers have issued 12 month price targets for LeMaitre Vascular's stock. Their LMAT share price forecasts range from $50.00 to $50.00. On average, they predict the company's stock price to reach $50.00 in the next year. This suggests a possible upside of 7.7% from the stock's current price.
View analysts price targets for LMAT
or view top-rated stocks among Wall Street analysts.

How have LMAT shares performed in 2022?

LeMaitre Vascular's stock was trading at $50.23 on January 1st, 2022. Since then, LMAT stock has decreased by 7.6% and is now trading at $46.42.
View the best growth stocks for 2022 here
.

When is LeMaitre Vascular's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our LMAT earnings forecast
.

How were LeMaitre Vascular's earnings last quarter?

LeMaitre Vascular, Inc. (NASDAQ:LMAT) posted its earnings results on Thursday, October, 27th. The medical instruments supplier reported $0.25 EPS for the quarter, missing the consensus estimate of $0.28 by $0.03. The medical instruments supplier had revenue of $39.03 million for the quarter, compared to the consensus estimate of $40.13 million. LeMaitre Vascular had a net margin of 13.22% and a trailing twelve-month return on equity of 9.33%.

How often does LeMaitre Vascular pay dividends? What is the dividend yield for LeMaitre Vascular?

LeMaitre Vascular declared a quarterly dividend on Thursday, October 27th. Investors of record on Thursday, November 17th will be given a dividend of $0.125 per share on Thursday, December 1st. This represents a $0.50 annualized dividend and a dividend yield of 1.08%. The ex-dividend date is Wednesday, November 16th.
Read our dividend analysis for LMAT
.

Is LeMaitre Vascular a good dividend stock?

LeMaitre Vascular (NASDAQ:LMAT) pays an annual dividend of $0.50 per share and currently has a dividend yield of 1.08%. The company has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 52.08%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, LMAT will have a dividend payout ratio of 42.37% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for LMAT.

What guidance has LeMaitre Vascular issued on next quarter's earnings?

LeMaitre Vascular issued an update on its fourth quarter 2022 earnings guidance on Thursday, November, 3rd. The company provided earnings per share (EPS) guidance of $0.24-$0.29 for the period, compared to the consensus earnings per share estimate of $0.32. The company issued revenue guidance of $39.80 million-$42.20 million, compared to the consensus revenue estimate of $41.87 million.

What is George W. LeMaitre's approval rating as LeMaitre Vascular's CEO?

13 employees have rated LeMaitre Vascular Chief Executive Officer George W. LeMaitre on Glassdoor.com. George W. LeMaitre has an approval rating of 33% among the company's employees. This puts George W. LeMaitre in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of LeMaitre Vascular own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LeMaitre Vascular investors own include AbbVie (ABBV), Sociedad Química y Minera de Chile (SQM), Gilead Sciences (GILD), Aurora Cannabis (ACB), Aurora Cannabis (ACBFF), NVIDIA (NVDA), Adobe (ADBE), Boeing (BA) and Salesforce (CRM).

What is LeMaitre Vascular's stock symbol?

LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."

Who are LeMaitre Vascular's major shareholders?

LeMaitre Vascular's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (14.85%), Conestoga Capital Advisors LLC (8.41%), Vanguard Group Inc. (6.57%), Copeland Capital Management LLC (5.57%), Geneva Capital Management LLC (4.06%) and State Street Corp (3.23%). Insiders that own company stock include David B Roberts, George W Lemaitre, George W Lemaitre, John A Roush, Joseph P Pellegrino Jr, Lawrence J Jasinski and Trent G Kamke.
View institutional ownership trends
.

How do I buy shares of LeMaitre Vascular?

Shares of LMAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LeMaitre Vascular's stock price today?

One share of LMAT stock can currently be purchased for approximately $46.42.

How much money does LeMaitre Vascular make?

LeMaitre Vascular (NASDAQ:LMAT) has a market capitalization of $1.02 billion and generates $154.42 million in revenue each year. The medical instruments supplier earns $26.91 million in net income (profit) each year or $0.96 on an earnings per share basis.

How many employees does LeMaitre Vascular have?

The company employs 450 workers across the globe.

Does LeMaitre Vascular have any subsidiaries?
The following companies are subsidiares of LeMaitre Vascular: Artegraft, Bio Nova Holdings Pty Ltd, Bio Nova International Pty Ltd, Biomateriali, CardioCel, Clinical Instruments, Credent, Endomed, Ideas for Medicine, Inavein, LeMaitre Acquisition LLC, LeMaitre Cardial SAS, LeMaitre Medical Technology (Shanghai) Co., LeMaitre Vascular, LeMaitre Vascular AS, LeMaitre Vascular GK, LeMaitre Vascular GmbH, LeMaitre Vascular Pty Ltd, LeMaitre Vascular S.r.l., LeMaitre Vascular SAS, LeMaitre Vascular Singapore Pte Ltd, LeMaitre Vascular Spain, LeMaitre Vascular Switzerland GmbH, LeMaitre Vascular ULC, LifeSpan, PeriVu, ProCol, Restore Flow Allografts, RestoreFlow, Syntel and Python, TRIVEX, Tru-Incise (Eze-Sit) OUS, Tru-Incise (Eze-Sit) US, UnBalloon, VCS Clip, VascuCel, Vascular Architects, Vascular Innovations, Vascutech Acquisition LLC, Vermed, Whittaker Screen Printing, XenoSure, and Xenotis Pty Ltd.
Read More
How can I contact LeMaitre Vascular?

LeMaitre Vascular's mailing address is 63 SECOND AVENUE, BURLINGTON MA, 01803. The official website for the company is www.lemaitre.com. The medical instruments supplier can be reached via phone at (781) 221-2266 or via fax at 781-425-5049.

This page (NASDAQ:LMAT) was last updated on 12/10/2022 by MarketBeat.com Staff